Boy in suit smiling
pipeline2.png
registry2.png
rideataxia2.png
advocacy2.png
energyball2.png
grassroots2.png

Featured FARA News and Blogs

Reata Pharmaceuticals Announces
FDA Approval of SKYCLARYS™ (Omaveloxolone)

View the recently updated
Clinical Management Guidelines for Friedreich Ataxia

Available Now! FARA’s Annual Donor Impact Report

Biogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia

Clinical Trials now Enrolling Volunteers Needed!

Activities & Events